Home > Press > Shrink Nanotechnologies to Present at Rodman and Renshaw Annual Global Investment Conference
Abstract:
Expert Thought Leaders in Medical Diagnostics and Biotechnology Will Be Providing Insights on Quickly Evolving Commercialization
Shrink Nanotechnologies, Inc. ("Shrink") (OTCBB: INKN), an innovative nanotechnology company that develops products, licenses its patent-pending technologies and acquires related assets in three core vertical markets: (i) medical diagnostics and sensors, (ii) biotechnology research and development tools and (iii) solar energy production, today announced that it plans to present at the Rodman and Renshaw Annual Global Investment Conference in New York on Friday, September 11, 2009 at 11:40 a.m. ET. The presentation will be held at the New York Palace Hotel in the Hubbard Salon (5th floor).
Presenting at the conference will be Dr. Michelle Khine, scientific founder, and Dr. Heiner Dreismann, director and expert in biotech and healthcare industries. Dr. Khine was recently named by MIT Technology Review as one of the top 35 global innovators under the age of 35. She is a veteran entrepreneur, with a successful venture-capitalist (Series B) backed company, in addition to being a widely published researcher, with multiple patents grants and honors. Currently, she is Assistant Professor of Bioengineering at University of California in Irvine. Dr. Dreismann has more than 24 years experience in the biotech and healthcare industries and served as the President and CEO of Roche Molecular Systems, Inc., leading a staff of more than 1,600 and growing the RMS molecular IVD business from $640M to $1.2B in annual sales.
Shrink is a FIGA business - bringing together leaders from the worlds of finance, industry, government and academia. This presentation is an example of Shrink bringing together industry leaders and academia in one setting.
Attendees will be given an overview of the Company's operations and strategic priorities, and review opportunities for its innovative technologies and intellectual property within the medical diagnostics and biotechnology sectors. Specific products that will be discussed include:
* StemDisc - embryoid body (EB) development platform for stem cell researchers; ability to culture up to 96,000 symmetrical stem cell development.
* CellAlign- tissue engineering applications for cardiac and nerve tissue; biodegradable non-periodic "band-aid" structure for tissue growth.
* ShrinkChip RPS - extremely low cost, highly flexible prototyping solution for the manufacture of microfluidic biochips; patent-pending desktop solution allows rapid design and fabrication of custom biochips.
* MetalFluor - diagnostic platform designed to inexpensively increase the sensitivity and specificity of luminescent based assays; potential to allow low-cost light detectors to enable more portable instrumentation for POC testing.
* OptiSol Solar Concentrator- creating, trapping, and transporting electrons; when `wrinkled,` the surface becomes a `light trap` and tunes all radiation to optimal silicon absorbing wavelengths.
To learn more about these products and the technology, please visit www.shrinknano.com. The presentation will be available to the public via a live web cast, which may be accessed by visiting www.wsw.com/webcast/rrshq15/inkn.ob.
####
About Shrink Nanotechnologies
Shrink is a first of its kind FIGA organization. FIGA companies are "for profit" businesses that bring together diverse contributions from leaders in the worlds of finance, industry, government and academia. Shrink`s solutions, including its diverse polymer substrates, nano-devices and biotech research tools, among others, are being designed to not only be ultra-function and mechanically superior in the solar energy, environmental detection, stem cell and biotechnology markets, they are also being made from biodegradable materials, including corn-based plastics. Shrink has created the ShrinkChip Manufacturing Solution which utilizes the unique characteristics of PolyShrink, Shrink`s core multi-grade plastic material. Made from a unique shrinkable thermo-plastic material, PolyShrink enable complex ultra-functional nano-structures to be designed at the macro-scale and shrunken down, while retaining the original designs on a much smaller nano scale. This flexible and elegant design and fabrication solution reduces costs by eliminating the need for expensive clean room equipment, vastly improving time-to-market for products in Shrink`s focused market segments.
For more information, please click here
Contacts:
Investors
Brainerd Communicators
Denise Roche, 212-986-6667
or
Media
Brainerd Communicators
Scott Cianciulli, 212-986-6667
Copyright © Shrink Nanotechnologies
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Simulating magnetization in a Heisenberg quantum spin chain April 5th, 2024
NRL charters Navy’s quantum inertial navigation path to reduce drift April 5th, 2024
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Nanomedicine
New micromaterial releases nanoparticles that selectively destroy cancer cells April 5th, 2024
Good as gold - improving infectious disease testing with gold nanoparticles April 5th, 2024
Researchers develop artificial building blocks of life March 8th, 2024
Sensors
Announcements
NRL charters Navy’s quantum inertial navigation path to reduce drift April 5th, 2024
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
Patents/IP/Tech Transfer/Licensing
Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023
Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020
Events/Classes
Researchers demonstrate co-propagation of quantum and classical signals: Study shows that quantum encryption can be implemented in existing fiber networks January 20th, 2023
Grants/Sponsored Research/Awards/Scholarships/Gifts/Contests/Honors/Records
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
Chemical reactions can scramble quantum information as well as black holes April 5th, 2024
Nanobiotechnology
New micromaterial releases nanoparticles that selectively destroy cancer cells April 5th, 2024
Good as gold - improving infectious disease testing with gold nanoparticles April 5th, 2024
Researchers develop artificial building blocks of life March 8th, 2024
Solar/Photovoltaic
Development of zinc oxide nanopagoda array photoelectrode: photoelectrochemical water-splitting hydrogen production January 12th, 2024
Shedding light on unique conduction mechanisms in a new type of perovskite oxide November 17th, 2023
Inverted perovskite solar cell breaks 25% efficiency record: Researchers improve cell efficiency using a combination of molecules to address different November 17th, 2023
Charged “molecular beasts” the basis for new compounds: Researchers at Leipzig University use “aggressive” fragments of molecular ions for chemical synthesis November 3rd, 2023
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||